NEW YORK (GenomeWeb News) - Applera and Beckman Coulter said today that they have finalized the terms of a patent suit regarding Beckman Coulter's capillary electrophoresis technology and Applera's allegations of breach of contract.
 
The companies said that the terms of the agreement are "consistent" with those of a preliminary agreement that they disclosed in April.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.